Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 14, 2015
Medication is an additional source of phosphate intake in chronic kidney disease patientsJ Sultana, U M Musazzi, Y Ingrasciotta, et al.
European Review for Medical and Pharmacological Sciences|December 4, 2020
Increase of renal resistive index and mineral metabolism disorder in patients with acute coronary syndrome with preserved renal functionS Lai, C Gaudio, A M Perrotta, et al.
Radiologia|March 26, 2019
Diagnostic yield of magnetic resonance imaging and intraoperative frozen section in the determination of deep myometrial invasion in endometrial cancerM F Sánchez, P I Causa Andrieu, C Latapie, et al.
Nutrients|December 11, 2019
Effect of Low-Protein Diet and Inulin on Microbiota and Clinical Parameters in Patients with Chronic Kidney DiseaseSilvia Lai, Alessio Molfino, Massimo Testorio, et al.
Journal of Pediatric Hematology/Oncology|August 13, 1999
Safety, tolerability, antiemetic efficacy, and pharmacokinetics of oral dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapyM J Coppes, R Yanofsky, S Pritchard, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|January 28, 2006
[Intrahepatic cholangiocarcinoma: case report]G P Cione, G Arciero, C P De Angelis, et al.
Nature Biotechnology|December 18, 2025
Engineered base editors with reduced bystander editing through directed evolutionRamiro M Perrotta, Svenja Vinke, Raphaël Ferreira, et al.
European Review for Medical and Pharmacological Sciences|July 20, 2022
Literature review on the cross-link between ocular and renal disease: renin angiotensin aldosterone system is a main actorS Lai, A M Perrotta, D Bagordo, et al.
Medical and Pediatric Oncology|July 9, 1999
Open-label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapyM J Coppes, R Lau, L C Ingram, et al.
Molecular Psychiatry|December 10, 2015
Fluoxetine effects on molecular, cellular and behavioral endophenotypes of depression are driven by the living environmentS Alboni, R M van Dijk, S Poggini, et al.
Pageof 7